Company · CIK 1847367
ALUMIS INC.
| CIK | 1847367 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | CA |
| Listed | ALMS (Nasdaq) |
| First annual or quarterly report | 2024-08-13 |
Offerings
3 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-294455 | 2026-03-19 | 2026-03-19 | 1 | |
| 333-288510 | 2025-07-03 | 2026-01-08 | 4 | |
| 333-280068 | 2024-06-07 | 2024-06-28 | 5 |
Filings
14| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-03-19 | S-3ASRShelf registered | 333-294455 | 0001104659-26-032158 |
| 2026-01-08 | 424B5Shelf takedown | 333-288510 | 0001104659-26-002203 |
| 2026-01-06 | 424B5Shelf takedown | 333-288510 | 0001104659-26-001410 |
| 2025-08-19 | EFFECTDeclared effective | 333-288510 | 9999999995-25-002674 |
| 2025-07-03 | S-3Shelf registered | 333-288510 | 0001104659-25-065745 |
| 2025-04-23 | EFFECTDeclared effective | 333-286660 | 9999999995-25-001216 |
| 2025-04-04 | EFFECTDeclared effective | 333-286178 | 9999999995-25-000990 |
| 2025-02-14 | DRSDraft made public | 377-07730 | 0001104659-25-013980 |
| 2024-06-28 | 424B4Final prospectus | 333-280068 | 0001104659-24-076337 |
| 2024-06-27 | EFFECTDeclared effective | 333-280068 | 9999999995-24-001994 |
| 2024-06-24 | S-1/AAmendment | 333-280068 | 0001104659-24-074108 |
| 2024-06-18 | S-1/AAmendment | 333-280068 | 0001104659-24-072513 |
| 2024-06-07 | S-1Registration filed | 333-280068 | 0001104659-24-069735 |
| 2024-04-11 | DRSDraft made public | 377-07178 | 0001104659-24-045928 |